PDO Screen – Patient-derived Organoids meet Cancer Modeling
Discover how patient-derived organoids can revolutionize oncology research by enabling accurate modeling of tumor biology and predicting patient response to treatment.
Discover how patient-derived organoids can revolutionize oncology research by enabling accurate modeling of tumor biology and predicting patient response to treatment.
Explore what the new legislative bill means for the future of ...
Learn how to select the right model for your immunotherapy ...
Explore HUB’s license offerings and how they apply to your organoid ...
Learn why you should invest in patient-derived HUB Organoids® for ...
In this last episode of our "Ask the experts" series we explore the ...
After discussing HUB Organoids™ applications to viral and oncology ...
In the first post from our "Ask the experts" series we have answered ...
HUB and STEMCELL Technologies experts gathered virtually for a ...